Stay updated on SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    0.3%
    Check dated 2025-01-12T17:07:00.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T12:21:45.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    4%
    Check dated 2024-12-07T10:32:16.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.
    Difference
    5%
    Check dated 2024-11-23T04:23:38.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Several key health-related URLs have been removed, including those related to genetics, melanoma, and rare diseases, which may impact access to important medical information.
    Difference
    0.7%
    Check dated 2024-11-15T22:50:06.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with numerous new resources added, including links to genetics information, melanoma details, and clinical trial data, while the previous version 2.12.1 has been removed.
    Difference
    6%
    Check dated 2024-11-08T18:03:22.000Z thumbnail image

Stay in the know with updates to SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.